IRIS
PEDERZOLI, FILIPPO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 334
NA - Nord America 332
AS - Asia 105
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
SA - Sud America 1
Totale 781
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 328
SE - Svezia 170
IT - Italia 66
SG - Singapore 46
RU - Federazione Russa 35
CN - Cina 33
DE - Germania 26
FI - Finlandia 14
IR - Iran 8
IE - Irlanda 7
EG - Egitto 5
FR - Francia 5
IN - India 5
CA - Canada 4
GB - Regno Unito 4
EU - Europa 3
JP - Giappone 3
HK - Hong Kong 2
ID - Indonesia 2
KR - Corea 2
NL - Olanda 2
PL - Polonia 2
TW - Taiwan 2
AR - Argentina 1
AU - Australia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
LT - Lituania 1
Totale 781
Salva come PNG Salva come JPEG
Città #
New York 55
Ashburn 47
Lawrence 38
Princeton 38
Singapore 29
Shanghai 27
Boardman 25
Milan 23
Rome 17
Moscow 16
Helsinki 14
Dublin 7
Hanover 7
Seattle 5
Turin 5
Segrate 4
Cairo 3
Pune 3
Woking 3
Arvada 2
Athens 2
Banha 2
Buffalo 2
Detroit 2
Frankfurt am Main 2
Hong Kong 2
Kingston 2
Krakow 2
Lyon 2
Mumbai 2
New Haven 2
Nuremberg 2
Romano di Lombardia 2
Seocho-gu 2
Silver Spring 2
Surakarta 2
Verona 2
Washington 2
Bologna 1
Chang-hua 1
Clifton 1
Falcone 1
Fort Lauderdale 1
Gunzenhausen 1
Jordan 1
Kaunas 1
Los Angeles 1
Martina Franca 1
Melbourne 1
Middlesbrough 1
Prague 1
Rozzano 1
Río Cuarto 1
Takoma Park 1
Tokyo 1
Torino 1
Woodbridge 1
Yuanlin 1
Zanjan 1
Totale 425
Salva come PNG Salva come JPEG
Nome #
Microbiome and bladder cancer 88
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 31
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 29
A feasibility study of preoperative pembrolizumab before radical nephroureterectomy in patients with high-risk, upper tract urothelial carcinoma: PURE-02 26
Aging, inflammation and DNA damage in the somatic testicular niche with idiopathic germ cell aplasia 24
Clinical Profile of Young Patients with Erectile Dysfunction: Preliminary Findings of a Real-life Cross-sectional Study 23
Leiomyoadenomatoid tumours of the epididymis: A new case report and review of the literature 23
Risk of health status worsening in primary infertile men: A prospective 10-year follow-up study 23
Bladder-sparing combination treatments for muscle-invasive bladder cancer: A plea for standardized assessment and definition of clinical trials endpoints 23
A global approach to improving penile cancer care 22
Unfavorable Cancer-specific Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients With Bladder Cancer and Squamous Cell Variant: A Multi-institutional Study 22
A risk calculator predicting recurrence in lymph node metastatic penile cancer 21
Contemporary Treatment Patterns and Outcomes for Patients with Penile Squamous Cell Carcinoma: Identifying Management Gaps to Promote Multi-institutional Collaboration 21
Infertile Men Have Higher Prostate-specific Antigen Values than Fertile Individuals of Comparable Age 21
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 21
High-risk Surgically Resected Renal Cell Carcinoma: Is There a Role for Adjuvant VEGF-TKI Inhibitors? 21
Efficacy and toxicity of antibody-drug conjugates in the treatment of metastatic urothelial cancer: A scoping review 21
Heavy cigarette smoking and alcohol consumption are associated with impaired sperm parameters in primary infertile men 20
Normal sperm parameters per se do not reliably account for fertility: A case–control study in the real-life setting 19
Intermediate- and high-risk nonmuscle invasive bladder cancer: Where do we stand? 19
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 18
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma 17
Clinical Outcomes of Patients With Metastatic Urothelial Carcinoma After Progression to Immune Checkpoint Inhibitors: A Retrospective Analysis by the Meet-Uro Group (Meet-URO 1 Study) 17
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? 17
Targetable gene fusions and aberrations in genitourinary oncology 16
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 15
Risk factors and survival outcomes for upstaging after inguinal lymph node dissection for cN1 penile squamous cell carcinoma 14
Causal contributors to tissue stiffness and clinical relevance in urology 14
Regenerative and engineered options for urethroplasty 13
The new era of precision urobiome: RE: “Characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study” by Chipollini et al 13
Re: Siamak Daneshmand, Azadeh Nazemi. Neoadjuvant Chemotherapy in Variant Histology Bladder Cancer: Current Evidence. Eur Urol Focus 2020;6:639–41 13
Testicular volume in infertile versus fertile white-European men: a case-control investigation in the real-life setting 13
Patterns of Recurrence following Inguinal Lymph Node Dissection for Penile Cancer: Optimizing Surveillance Strategies 13
Semen infections in men with primary infertility in the real-life setting 12
Predicting the pathologic complete response after neoadjuvant pembrolizumab in muscle-invasive bladder cancer 12
Revolutionizing care for rare genitourinary tumours 12
Progressive alteration of murine bladder elasticity in actinic cystitis detected by Brillouin microscopy 11
Optimising the selection of candidates for neoadjuvant chemotherapy amongst patients with node-positive penile squamous cell carcinoma 11
The Value of Multiparametric Magnetic Resonance Imaging Sequences to Assist in the Decision Making of Muscle-invasive Bladder Cancer 11
Early diagnosis of bladder cancer by photoacoustic imaging of tumor-targeted gold nanorods 10
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 10
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm? 9
Neoadjuvant chemotherapy for lymph node-positive penile cancer: Current evidence and knowledge 9
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients 9
Whole exome data prioritization unveils the hidden weight of Mendelian causes of male infertility. A report from the first Italian cohort 8
Topographic modification of the extracellular matrix precedes the onset of bladder cancer 7
Re: High blood pressure is a highly prevalent but unrecognised condition in primary infertile men: Results of a cross-sectional study 4
Micro-mechanical fingerprints of the rat bladder change in actinic cystitis and tumor presence 1
Stool Microbiome Signature Associated with Response to Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Cancer 1
The Gut and Urinary Microbiota: A Rising Biomarker in Genitourinary Malignancies 1
null 1
null 1
null 1
null 1
null 1
null 1
Totale 855
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.438
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.438
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205 1 0 0 0 0 0 0 0 2 2 0 0
2020/202122 0 0 0 2 0 15 5 0 0 0 0 0
2021/2022101 0 10 2 20 3 4 15 9 5 7 3 23
2022/2023319 93 71 26 16 5 36 11 26 15 5 5 10
2023/2024320 11 28 34 31 30 74 10 41 1 4 8 48
2024/202587 87 0 0 0 0 0 0 0 0 0 0 0
Totale 855